These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 8468276

  • 21. Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
    Hallemeier CL, Girgis MD, Blum WG, Brown RA, Khoury HJ, Devine SM, Vij R, Lin HS, DiPersio JF, Adkins DR.
    Biol Blood Marrow Transplant; 2006 Jul; 12(7):749-57. PubMed ID: 16785064
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Recent advances in the management of therapy-related myelodysplastic syndromes and acute myeloid leukemia.
    Klimek VM.
    Curr Opin Hematol; 2013 Mar; 20(2):137-43. PubMed ID: 23343830
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Secondary acute myelogenous leukemia following treatment with oral etoposide.
    Katato K, Flaherty L, Varterasian M.
    Am J Hematol; 1996 Sep; 53(1):54-5. PubMed ID: 8813107
    [No Abstract] [Full Text] [Related]

  • 28. Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
    Costa LJ, Rodriguez V, Porrata LF, Lacy MQ, Elliott MA, Gertz MA, Gastineau DA, Litzow MR.
    Bone Marrow Transplant; 2008 Oct; 42(7):497-8. PubMed ID: 18622421
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
    Abdelhameed A, Pond GR, Mitsakakis N, Brandwein J, Chun K, Gupta V, Kamel-Reid S, Lipton JH, Minden MD, Schimmer A, Schuh A, Yee K, Messner HA.
    Cancer; 2008 Apr 01; 112(7):1513-21. PubMed ID: 18286528
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Role of aggressive treatment strategies for myelodysplastic syndromes].
    Aul C, Germing U, Minning H, Kobbe G, Gattermann N, Südhoff T, Meckenstock G, Söhngen D, Heyll A.
    Praxis (Bern 1994); 1999 Mar 04; 88(10):431-8. PubMed ID: 10199215
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Snijder S, Mellink CH, van der Lelie H.
    Cancer Genet Cytogenet; 2008 Jan 15; 180(2):149-52. PubMed ID: 18206542
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep 15; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.